AL-LAD - Revision history

Orion at 00:42, 17 August 2013

2013-08-17T00:42:34Z

Orion at 22:43, 16 August 2013

2013-08-16T22:43:51Z

Orion at 22:42, 16 August 2013

2013-08-16T22:42:41Z

Orion at 22:41, 16 August 2013

2013-08-16T22:41:45Z

Orion at 22:41, 16 August 2013

2013-08-16T22:41:08Z

Orion at 22:40, 16 August 2013

2013-08-16T22:40:10Z

Orion at 22:30, 16 August 2013

2013-08-16T22:30:58Z

Endlessness at 22:25, 16 August 2013

2013-08-16T22:25:07Z

Endlessness: /* Pharmacology, toxicity and general safety */

2013-08-16T22:18:20Z

‎Pharmacology, toxicity and general safety

Endlessness: /* Analysis of AL-LAD */

2013-08-16T22:14:04Z

‎Analysis of AL-LAD

@@ Line 9: / Line 9: @@
 * Mental: paranoia, fear, and panic. No other known specific physical risks at this time (but likely similar to LSD).
+|
-* AL-LAD is a substance with very little published used, with little known about its pharmacological or behavioral risks. The LD50 (median lethal dose) is not known.
+* AL-LAD is a substance with very little published about, with little known about its pharmacological or behavioral risks. The LD50 (median lethal dose) is not known.
 * Elaborate studies on this substance have not been performed, so long term effects are UNKNOWN!
 }}

@@ Line 7: / Line 7: @@
 * Nausea, vasoconstriction (mostly when combined with other vasoconstricting substances like LSD), unusual body sensations (facial flushing, chills, goosebumps, body energy), slight increase in heart rate, difficulty focusing
+|
-* mental: paranoia, fear, and panic. No other known risks at this time (likely similar to LSD).
+* Mental: paranoia, fear, and panic. No other known specific physical risks at this time (but likely similar to LSD).
+|
 * AL-LAD is a substance with very little published used, with little known about its pharmacological or behavioral risks. The LD50 (median lethal dose) is not known.

@@ Line 7: / Line 7: @@
 * Nausea, vasoconstriction (mostly when combined with other vasoconstricting substances like LSD), unusual body sensations (facial flushing, chills, goosebumps, body energy), slight increase in heart rate, difficulty focusing
+|
-* paranoia, fear, and panic, no other known risks at this time (likely similar to LSD).
+* mental: paranoia, fear, and panic. No other known risks at this time (likely similar to LSD).
+|
 * AL-LAD is a substance with very little published used, with little known about its pharmacological or behavioral risks. The LD50 (median lethal dose) is not known.

@@ Line 7: / Line 7: @@
 * Nausea, vasoconstriction (mostly when combined with other vasoconstricting substances like LSD), unusual body sensations (facial flushing, chills, goosebumps, body energy), slight increase in heart rate, difficulty focusing
+|
-* paranoia, fear, and panic, no other known risks at this time
+* paranoia, fear, and panic, no other known risks at this time (likely similar to LSD).
+|
 * AL-LAD is a substance with very little published used, with little known about its pharmacological or behavioral risks. The LD50 (median lethal dose) is not known.

@@ Line 7: / Line 7: @@
 * Nausea, vasoconstriction (mostly when combined with other vasoconstricting substances like LSD), unusual body sensations (facial flushing, chills, goosebumps, body energy), slight increase in heart rate, difficulty focusing
+|
-* paranoia, fear, and panic
+* paranoia, fear, and panic, no other known risks at this time
+|
 * AL-LAD is a substance with very little published used, with little known about its pharmacological or behavioral risks. The LD50 (median lethal dose) is not known.

@@ Line 1: / Line 1: @@
 {{Safety_profile
+|
@@ Line 15: / Line 13: @@
 }}
 == Brief overview - What is AL-LAD? ==

← Older revision		Revision as of 22:25, 16 August 2013
Line 1:		Line 1:
	[[Image:AL-LAD.png\|right\|thumb\|200px]]		[[Image:AL-LAD.png\|right\|thumb\|200px]]

		+	{{Safety_profile
		+	\|
		+	* Psychedelic
		+	\|
		+	* Open and closed eye visuals, euphoria, change in perception of time
		+	\|
		+	* Nausea, vasoconstriction (mostly when combined with other vasoconstricting substances like LSD), unusual body sensations (facial flushing, chills, goosebumps, body energy), slight increase in heart rate, difficulty focusing
		+	\|
		+	* paranoia, fear, and panic, dystonia (rare), seizure (rare), death (rare)
		+	\|
		+	* AL-LAD is a substance with very little published used, with little known about its pharmacological or behavioral risks. The LD50 (median lethal dose) is not known.
		+	* Elaborate studies on this substance have not been performed, so long term effects are UNKNOWN!
		+	}}

@@ Line 21: / Line 21: @@
 DURATION : 6 - 8 hours.
-Very little is known at this stage about the toxicity of AL-LAD. AL-LAD is every bit as much as potent as it's sister molecule LSD and should be treated with equal respect. No deaths have been reported due to it's usage and so far there is no data for lasting negative physical effect. This chemical is still a powerful psychedelic and the effects are mostly mental/visual. Most online reports have been positive with no complaints of negative physical effect after the experience has ran its course.
+Very little is known at this stage about the toxicity of AL-LAD and potential long-term effects. As with any RC, caution should be exercised.
 Bad trips are always possible with almost any psychedelic and AL-LAD is no exception, with reports mentioning things becoming much too intense and 'cartoon like' at higher dosages. Always make sure you know how much you are ingesting and do so in a safe environment where you feel comfortable. NEVER ingest a psychedelic if you will be working or driving.
-There scarce data regarding the combination of AL-LAD and other substances. Combination with MAOIs (monoamine oxidase inhibitors) carries the same risk as with many other psychedelics, however since this combination has not been documented and can NOT be recommended at this point.
+There scarce data regarding the combination of AL-LAD and other substances. Combination with MAOIs (monoamine oxidase inhibitors) carries the same risk as with many other psychedelics, however since this combination has not been documented it can NOT be recommended at this point.
 == Dosages and consumption methods ==

← Older revision		Revision as of 22:14, 16 August 2013
Line 36:		Line 36:

	== Analysis of AL-LAD ==		== Analysis of AL-LAD ==
		+
		+	http://www.ecstasydata.org/view.php?ID=2829
		+	[[File:Al lad spectra.jpg]]

	== Scientific publications ==		== Scientific publications ==